In the rapidly evolving landscape of pharmaceutical development, artificial intelligence (AI) has emerged as a powerful tool that promises to revolutionize how we discover, develop, and manufacture drugs. However, how AI is applied to drug discovery depends on the type of drug being developed according to Wayne Doyle, head of platform at Eclipsebio. Specifically for mRNA-based therapies, AI can further enhance an already quick development process. While…
Article Source
https://www.biospace.com/beyond-black-box-how-data-driven-ai-is-transforming-rna-medicine-development
